Enhancing osteoconduction of PLLA-based nanocomposite scaffolds for bone regeneration using different biomimetic signals to MSCs

International Journal of Molecular Sciences

Volumn 13, Issue 2, 2012, Pages 2439-2458

  Ciapetti, Gabriela ^a   Granchi, Donatella ^a   Devescovi, Valentina ^a   Baglio, Serena R ^a   Leonardi, Elisa ^a   Martini, Desirèe ^b   Jurado, Maria Jesus ^c   Olalde, Beatriz ^c   Armentano, Ilaria ^d   Kenny, Josè M ^d   Walboomers, Frank X ^e   Alava, Josè Inaki ^c   Baldini, Nicola ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c TECNALIA RESEARCH AND INNOVATION   (Spain)

^d UNIVERSITY OF PERUGIA   (Italy)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomimetic nanocomposites; Bone tissue engineering; Mesenchymal stem cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; MOLECULAR SCAFFOLD; NANOCOMPOSITE; POLYLACTIC ACID; POLYMER; SINGLE WALLED NANOTUBE; BIOMIMETIC MATERIALS; LACTIC ACID; NANOCOMPOSITES; POLY(LACTIC ACID); POLYMERS;

ADULT; AGED; ARTICLE; BIOMIMETICS; BONE CONDUCTION; BONE MATURATION; BONE MINERALIZATION; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MESENCHYMAL STROMA CELL; NANOBIOTECHNOLOGY; NANOFABRICATION; SCORING SYSTEM; STRUCTURE ANALYSIS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GUIDED TISSUE REGENERATION; HUMANS; INSTRUMENTATION; MESENCHYMAL STROMAL CELLS; METHODS; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

AGED; BIOMIMETIC MATERIALS; BONE REGENERATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GUIDED TISSUE REGENERATION; HUMANS; LACTIC ACID; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NANOCOMPOSITES; OSTEOBLASTS; OSTEOGENESIS; POLYMERS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84857665847     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13022439     Document Type: Article

References (67)

1. Fröhlich, M.; Grayson, W.L.; Wan, L.Q.; Marolt, D.; Drobnic, M.; Vunjak-Novakovic, G. Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr. Stem Cell Res. Ther. 2008, 3, 254-264.
2. Baldini, N.; Cenni, E.; Ciapetti, G.; Granchi, D.; Savarino, L. Bone Repair Biomaterials. In Bone Repair and Regeneration, 1st ed.; Planell, J.A., Ed.; Woodhead Publishing Limited: Cambridge, UK, 2009; pp. 69-105.
3. Khan, Y.; Yaszemski, M.J.; Mikos, A.G.; Laurencin, C.T. Tissue engineering of bone: material and matrix consideration. J. Bone Joint Surg. Am. 2008, 90, S36-S42.
4. Ciapetti, G.; Ambrosio, L.; Marletta, G.; Baldini, N.; Giunti, A. Human bone marrow stromal cells: in vitro expansion and differentiation for bone engineering. Biomaterials 2006, 27, 6150-6160.
5. Patterson, T.E.; Kumagai, K.; Griffith, L.; Muschler, G.F. Cellular strategies for enhancement of fracture repair. J. Bone Joint Surg. Am. 2008, 90, S111-S119.
6. Tabata, Y. Biomaterial technology for tissue engineering applications. J. R. Soc. Interface 2009, 6, S311-S324.
7. Gimble, J.M.; Guilak, F.; Nuttall, M.E.; Sathishkumar, S.; Vidal, M.; Bunnell, B.A. In vitro differentiation potential of mesenchymal stem cells. Transfus. Med. Hemother. 2008, 35, 228-238.
8. Burdick, J.A.; Vunjak-Novakovic, G. Engineered microenvironments for controlled stem cell. Differ. Tissue Eng. 2009, 15, 205-219.
9. Rezwan, K.; Chen, Q.Z.; Blazer, J.J.; Boccaccini, A.R. Biodegradable and bioactive porous polymer/ inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006, 27, 3413-3431.
10. Ayala, R.; Zhang, C.; Yang, D.; Hwang, Y.; Aung, A.; Shroff, S.S.; Arce, F.T.; Lal, R.; Arya, G.; Varghese, S. Engineering the cell-material interface for controlling stem cell adhesion, migration, and differentiation. Biomaterials 2011, 32, 3700-3711.
11. Yanoso-Scholl, L.; Jacobson, J.A.; Bradica, G.; Lerner, A.L.; O'Keefe, R.J.; Schwarz, E.M.; Zuscik, M.J.; Awad, H.A. Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering. J. Biomed. Mater. Res. A 2010, 95, 717-726.
12. Bettinger, C.J.; Langer, R.; Borenstein, J.T. Engineering substrate micro- and nanotopography to control cell function. Angew. Chem. Int. Ed. Engl. 2009, 48, 5406-5415.
13. Damadzadeh, B.; Labari, H.; Skrifvars, M.; Aiola, K.; Moritz, N.; Vallittu, P.K. Effect of ceramic filler content on the mechanical and thermal behaviour of poly-L-lactic acid and poly-L-lactic-coglycolic acid composites for medical applications. J. Mater. Sci. Mater. Med. 2010, 21, 2523-2531.
14. Vagaská, B.; Bacáková, L.; Filová, E.; Balík, K. Osteogenic cells on bio-inspired materials for bone tissue engineering. Physiol. Res. 2010, 59, 309-322.
15. Hanson, A.D.; Wall, M.E.; Pourdeyhimi, B.; Loboa, E.G. Effects of oxygen plasma treatment on adipose-derived human mesenchymal stem cell adherence to poly(L-lactic acid) scaffolds. J. Biomater. Sci. Polym. Ed. 2007, 18, 1387-1400.
16. Desmet, T.; Morent, R.; De Geyter, N.; Leys, C.; Schacht, E.; Dubruel, P. Nonthermal plasma technology as a versatile strategy for polymeric biomaterials surface modification: A review. Biomacromolecules 2009, 10, 2351-2378.
17. Khan, S.N.; Lane, J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin. Biol. Ther. 2004, 4, 741-748.
18. Valdes, M.A.; Thakur, N.A.; Namdari, S.; Ciombor, D.M.; Palombo, M. Recombinant bone morphogenic protein-2 in orthopaedic surgery: A review. Arch. Orthop. Trauma Surg. 2009, 129, 1651-1657.
19. Chou, Y.F.; Zuk, P.A.; Chang, T.L.; Benhaim, P.; Wu, B.M. Adipose-derived stem cells and BMP2: part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects. Connect. Tissue Res. 2011, 52, 109-118.
20. Singh, M.; Berkland, C.; Detamore, M.S. Strategies and applications for incorporatine physical and chemical signal gradients in tissue engineering. Tissue Eng: Part B 2008, 14, 341-366.
21. Granero-Moltó, F.; Weis, J.A.; Miga, M.I.; Landis, B.; Myers T.J.; O'Rear, L.; Longobardi, L.; Jansen, E.D.; Mortlock, D.P.; Spagnoli, A. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 2009, 27, 1887-1898.
22. Kallai, I.; van Lente, G.H.; Buffoni, D.; Zilberman, Y.; Müller, R.; Pelled, G.; Gazit, D. Quantitative, structural, and image-based mechanical analysis of nonunion fracture repaired by genetically engineered mesenchymal stem cells. J. Biomech. 2010, 43, 2315-2320.
23. Jorgensen, C.; Djouad, F.; Bouffi, C.; Frugala, D.; Noel, D. Multipotent mesenchymal stromal cells in articular diseases. Best Pract. Res. Clin. Rheumat. 2008, 22, 269-284.
24. Abdallah, B.M.; Kassem, M. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J. Cell. Physiol. 2008, 218, 9-12.
25. Huang, N.F.; Chu, J.; Lee, R.J.; Li, S. Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression. Acta Biomater. 2010, 6, 3947-3956.
26. Lee, J.; Cuddihy, M.J.; Kotov, N.A. Three-dimensional cell culture matrices: State of the art. Tissue Eng. Part B Rev. 2008, 14, 61-86.
27. Dutta, R.C.; Dutta, A.K. Cell-interactive 3D-scaffold; advances and applications. Biotechnol. Adv. 2009, 27, 334-339.
28. Anselme, K.; Davidson, P.; Popa, A.M.; Giazzon, M.; Liley, M.; Ploux, L. The interaction of cells and bacteria with surfaces structured at the nanometre scale. Acta Biomater. 2010, 6, 3824-3846.
29. Sitharaman, B.; Shi, X.; Walboomers, X.F.; Liao, H.; Cuijpers, V.; Wilson, L.J.; Mikos, A.G.; Jansen, J.A. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 2008, 43, 362-370.
30. Bhattacharyya, S.; Guillot, S.; Dabboue, H.; Tranchant, J.F.; Salvetat, J.P. Carbon nanotubes as structural nanofibers for hyaluronic acid hydrogel scaffolds. Biomacromolecules 2008, 9, 505-509.
31. Cheung, W.; Pontoriero, F.; Taratula, O.; Chen, A.M.; He, H. DNA and carbon nanotubes as medicine. Adv. Drug Deliv. Rev. 2010, 62, 633-649.
32. Bianco, A.; Del Gaudio, C.; Baiguera, S.; Armentano, I.; Bertarelli, C.; Dottori, M.; Bultrini, G.; Lucotti, A.; Kenny, J.M.; Folin, M. Microstructure and cytocompatibility of electrospun nanocomposites based on poly(epsilon-caprolactone) and carbon nanostructures. Int. J. Artif. Organs 2010, 33, 271-282.
33. Holt, B.D.; Short, P.A.; Rape, A.D.; Wang, Y.L.; Islam, M.F.; Dahl, K.N. Carbon nanotubes reorganize actin structures in cells and ex vivo. ACS Nano 2010, 4, 4872-4878.
34. Guarino, V.; Taddei, P.; Di Foggia, M.; Fagnano, C.; Ciapetti, G.; Ambrosio, L. The influence of hydroxyapatite particles on in vitro degradation behavior of poly -epsilon-caprolactone based composite scaffolds. Tissue Eng. Part A 2009, 15, 3655-3668.
35. Tami, A.E.; Leitner, M.M.; Baucke, M.G.; Mueller, T.L.; van Lente, G.H.; Müller, R.; Ito, K. Hydroxyapatite particles maintain peri-implant bone mantle during osseointegration in osteoporotic bone. Bone 2009, 45, 1117-1124.
36. Rehfeldt, F.; Engler, A.J.; Eckhardt, A.; Ahmed, F.; Discher, D.E. Cell responses to the mechanochemical microenvironment-Implications for regenerative medicine and drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 1329-1339.
37. Poulsson, A.H.; Mitchell, S.A.; Davidson, M.R.; Johnstone, A.J.; Emmison, N.; Bradley, R.H. Attachment of human primary osteoblast cells to modified polyethylene surfaces. Langmuir 2009, 25, 3718-3727.
38. Marletta, G.; Ciapetti, G.; Satriano, C.; Perut, F.; Salerno, M.; Baldini, N. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsilon-caprolactone. Biomaterials 2007, 28, 1132-1140.
39. Osycza, A.M.; Diefenderfer, D.L.; Bhargave, G.; Leboy, P.S. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004, 176, 109-119.
40. Patel, Z.S.; Young, S.; Tabata, Y.; Jansen, J.A.; Wong, M.E.K.; Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43, 931-940.
41. Fu, K.; Xu, Q.; Czernuszka, J.; McKenna, C.E.; Ebetino, F.H.; Russell, R.G.; Triffitt, J.T.; Xia, Z. Prolonged osteogenesis from human mesenchymal stem cells implanted in immunodeficient mice by using coralline hydroxyapatite incorporating rhBMP2 microspheres. J. Biomed. Mater. Res. A 2010, 92, 1256-1264.
42. Haidar, Z.S.; Hamdy, R.C.; Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol. Lett. 2009, 31, 1825-1835.
43. Granchi, D.; Ochoa, G.; Leonardi, E.; Devescovi, V.; Baglio, S.R.; Osaba, L.; Baldini, N.; Ciapetti, G. Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion. Tissue Eng. Part C Methods 2010, 16, 511-524.
44. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.; Deng, J.M.; Behringer, R.R.; de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108, 17-29.
45. Huang, W.; Yang, S.; Shao, J.; Li, Y.P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front. Biosci. 2007, 12, 3068-3092.
46. Lai, C.F.; Cheng, S.L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J. Biol. Chem. 2002, 277, 15514-15522.
47. Ueno, A.; Miwa, Y.; Miyoshi, K.; Horiguchi, T.; Inoue, H.; Ruspata, I.; Abe, K.; Yamashita, K.; Hayashi, E.; Noma, T. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization. J. Cell. Physiol. 2006, 209, 322-332.
48. Landis, W.J.; Silver, F.H. Mineral deposition in the extracellular matrices of vertebrate tissues: Identification of possible apatite nucleation sites on type I collagen. Cells Tissues Organs 2009, 189, 20-24.
49. Raymond, M.H.; Schutte, B.C.; Torner, J.C.; Burns, T.L.; Willing, M.C. Osteocalcin: genetic and physical mapping of the human gene BGLAP and its potential role in postmenopausal osteoporosis. Genomics 1999, 60, 210-217.
50. Wewer, U.M.; Ibaraki, K.; Schjørring, P.; Durkin, M.E.; Young, M.F.; Albrechtsen, R. A potential role for tetranectin in mineralization during osteogenesis. J. Cell Biol. 1994, 127, 1767-1775.
51. Ogata, Y. Bone sialoprotein and its transcriptional regulatory mechanism. J. Periodontal Res. 2008, 43, 127-135.
52. Motamed, K. SPARC (osteonectin/BM-40). Int. J. Biochem. Cell Biol. 1999, 31, 1363-1366.
53. Coutu, D.L.; Wu, J.H.; Monette, A.; Rivard, G.E.; Blostein, M.D.; Galipeau, J. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J. Biol. Chem. 2008, 283, 17991-18001.
54. Kong, L.; Tian, Q.; Guo, F.; Mucignat, M.T.; Perris, R.; Sercu, S.; Merregaert, J.; Di Cesare, P.E.; Liu, C.J. Interaction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth. Matrix Biol. 2010, 29, 276-286.
55. Iba, K.; Sawada, N.; Chiba, H.; Wewer, U.M.; Ishii, S.; Mori, M. Transforming growth factor beta 1 downregulates dexamethasone-induced tetranectin gene expression during the in vitro mineralization of the human osteoblastic cell line SV-HFO. FEBS Lett. 1995, 373, 1-4.
56. Gori, F.; Hofbauer, L.C.; Dunstan, C.R.; Spelsberg, T.C.; Khosla, S.; Riggs, B.L. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromalosteoblast lineage cells is developmentally regulated. Endocrinology 2000, 41, 4768-4776.
57. Gregory, C.A.; Gunn, W.G.; Reyes, E.; Smolarz, A.J.; Munoz, J.; Spees, J.L.; Prockop, D.J. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann. N. Y. Acad. Sci. 2005, 1049, 97-106.
58. van der Zande, M.; Walboomers, X.F.; Brännvall, M.; Olalde, B.; Jurado, M.J.; Alava, J.L.; Jansen, J.A. Genetic profiling of osteoblast-like cells cultured on a novel bone reconstructive material.; consisting of poly-l-lactide.; carbon nanotubes and microhydroxyapatite.; in the presence of bone morphogenetic protein-2. Acta Biomater. 2010, 6, 4352-4360.
59. Lian, J.B.; Stein, G.S. Concepts of Osteoblast Growth and Differentiation: Basis for Modulation of Bone Cell Development and Tissue Formation. Crit. Rev. Oral Biol. Med. 1992, 3, 369-305.
60. Schop, D.; Janssen, F.W.; van Rijn, L.D.S.; Fernandes, H.; Bloem, R.M.; de Bruijn, J.D.; van Dijkhuizen-Radersma, R. Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng. Part A 2009, 15, 1877-1886.
61. Osyczka, A.M.; Diefenderfer, D.L.; Bhargave, G.; Leboy, P.S. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004, 176, 109-119.
62. Wang, A.; Ding, X.; Sheng, S.; Yao, Z. Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells. Yonsei Med. J. 2010, 51, 740-745.
63. Sung Nam, Y.; Gwan Park, T. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J. Biomed. Mater. Res. 1999, 47, 8-17
64. Armentano, I.; Ciapetti, G.; Pennacchi, M.; Dottori, M.; Devescovi, V.; Granchi, D.; Baldini, N.; Olalde, B.; Jurado, M.J.; Marquinez Alava, J.I.; Kenny, J.M. Role of PLLA plasma surface modification in the interaction with human marrow stromal cells. J. Appl. Pol. Sci. 2009, 114, 3602-3611.
65. Leonardi, E.; Ciapetti, G.; Baglio, S.R.; Devescovi, V.; Baldini, N.; Granchi, D. Osteogenic properties of late adherent subpopulations of human bone marrow stromal cells. Histochem. Cell Biol. 2009, 132, 547-557.
66. Mouritzen, P.; Noerholm, M.; Nielsen, P.S.; Jacobsen, N.; Lomholt, C.; Pfundheller, H.M.; Tolstrup, N. ProbeLibrary: A new method for faster design and execution of quantitative real-time PCR. Nat. Methods 2005, 12, 313-316.
67. Roche Applied Science. Available online: https://www.roche-applied-science.com/sis/rtpcr/upl (accessed on 20 February 2012).